4.4 Editorial Material

The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Whole-genome characterization of chemoresistant ovarian cancer

Ann-Marie Patch et al.

NATURE (2015)

Editorial Material Oncology

The Clinical Relevance of Cancer Cell Lines

Jean-Pierre Gillet et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)

Review Pharmacology & Pharmacy

Collateral sensitivity as a strategy against cancer multidrug resistance

Kristen M. Pluchino et al.

DRUG RESISTANCE UPDATES (2012)

Review Pharmacology & Pharmacy

Drug resistance in the mouse cancer clinic

Sven Rottenberg et al.

DRUG RESISTANCE UPDATES (2012)

Review Pharmacology & Pharmacy

Drug resistance: Still a daunting challenge to the successful treatment of AML

Brian C. Shaffer et al.

DRUG RESISTANCE UPDATES (2012)

Article Medicine, Research & Experimental

Clinical Relevance of Multidrug Resistance Gene Expression in Ovarian Serous Carcinoma Effusions

Jean-Pierre Gillett et al.

MOLECULAR PHARMACEUTICS (2011)

Article Multidisciplinary Sciences

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

Jean-Pierre Gillet et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Oncology

Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor

Elizabeth Fox et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2007)

Article Biochemistry & Molecular Biology

Characterization of gene rearrangements leading to activation of MDR-1

Lyn M. Huff et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Review Oncology

Multidrug resistance in cancer: Role of ATP-dependent transporters

MM Gottesman et al.

NATURE REVIEWS CANCER (2002)